Logo image of TRX

TRX GOLD CORP (TRX) Stock Fundamental Analysis

NYSEARCA:TRX - CA87283P1099 - Common Stock

0.3501 USD
+0 (+0.46%)
Last: 8/26/2025, 8:05:11 PM
0.353 USD
+0 (+0.83%)
After Hours: 8/26/2025, 8:05:11 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TRX. TRX was compared to 155 industry peers in the Metals & Mining industry. TRX has a medium profitability rating, but doesn't score so well on its financial health evaluation. TRX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year TRX has reported negative net income.
TRX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: TRX reported negative net income in multiple years.
In multiple years TRX reported negative operating cash flow during the last 5 years.
TRX Yearly Net Income VS EBIT VS OCF VS FCFTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

TRX's Return On Assets of 1.36% is fine compared to the rest of the industry. TRX outperforms 61.94% of its industry peers.
TRX has a Return On Equity of 2.79%. This is in the better half of the industry: TRX outperforms 63.87% of its industry peers.
TRX has a better Return On Invested Capital (9.26%) than 78.71% of its industry peers.
TRX had an Average Return On Invested Capital over the past 3 years of 8.16%. This is below the industry average of 12.86%.
The last Return On Invested Capital (9.26%) for TRX is above the 3 year average (8.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.36%
ROE 2.79%
ROIC 9.26%
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
TRX Yearly ROA, ROE, ROICTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

TRX has a Profit Margin of 3.20%. This is in the better half of the industry: TRX outperforms 65.16% of its industry peers.
TRX has a Operating Margin of 20.68%. This is in the better half of the industry: TRX outperforms 72.26% of its industry peers.
The Gross Margin of TRX (37.60%) is better than 75.48% of its industry peers.
Industry RankSector Rank
OM 20.68%
PM (TTM) 3.2%
GM 37.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRX Yearly Profit, Operating, Gross MarginsTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

TRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TRX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, TRX has more shares outstanding
TRX has a worse debt/assets ratio than last year.
TRX Yearly Shares OutstandingTRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
TRX Yearly Total Debt VS Total AssetsTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

TRX has an Altman-Z score of 0.16. This is a bad value and indicates that TRX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.16, TRX is doing worse than 85.16% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that TRX is not too dependend on debt financing.
TRX's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. TRX outperforms 67.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACC0.99
WACC9.34%
TRX Yearly LT Debt VS Equity VS FCFTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.77 indicates that TRX may have some problems paying its short term obligations.
TRX has a Current ratio of 0.77. This is amonst the worse of the industry: TRX underperforms 89.68% of its industry peers.
TRX has a Quick Ratio of 0.77. This is a bad value and indicates that TRX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.35, TRX is doing worse than 91.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.35
TRX Yearly Current Assets VS Current LiabilitesTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

TRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
TRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.97%.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)29.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, TRX will show a very strong growth in Revenue. The Revenue will grow by 26.35% on average per year.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.19%
Revenue Next 2Y26.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
TRX Yearly Revenue VS EstimatesTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2022 2023 2024 2025 2026 20M 40M 60M
TRX Yearly EPS VS EstimatesTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 0.06

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 5.20 indicates a rather cheap valuation of TRX.
Based on the Price/Forward Earnings ratio, TRX is valued cheaply inside the industry as 98.71% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.67. TRX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 5.2
TRX Price Earnings VS Forward Price EarningsTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRX is valued cheaper than 80.65% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.62
TRX Per share dataTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

TRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRX GOLD CORP

NYSEARCA:TRX (8/26/2025, 8:05:11 PM)

After market: 0.353 +0 (+0.83%)

0.3501

+0 (+0.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-14 2025-07-14/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners2.12%
Inst Owner Change18.72%
Ins Owners1.45%
Ins Owner ChangeN/A
Market Cap99.48M
Analysts80
Price Target1.22 (248.47%)
Short Float %0.04%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-149.5%
Min EPS beat(2)-199.01%
Max EPS beat(2)-100%
EPS beat(4)0
Avg EPS beat(4)-112.38%
Min EPS beat(4)-199.01%
Max EPS beat(4)-50.49%
EPS beat(8)0
Avg EPS beat(8)-118.56%
EPS beat(12)0
Avg EPS beat(12)-112.38%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-30.92%
Min Revenue beat(2)-34.44%
Max Revenue beat(2)-27.4%
Revenue beat(4)0
Avg Revenue beat(4)-23.13%
Min Revenue beat(4)-34.44%
Max Revenue beat(4)-7.94%
Revenue beat(8)0
Avg Revenue beat(8)-21.52%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)-80%
EPS NY rev (3m)-80%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.67%
Revenue NY rev (1m)-18.36%
Revenue NY rev (3m)-18.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.2
P/S 2.08
P/FCF N/A
P/OCF 7.18
P/B 1.82
P/tB 1.82
EV/EBITDA 7.62
EPS(TTM)0
EYN/A
EPS(NY)0.07
Fwd EY19.23%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.05
OCFY13.93%
SpS0.17
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.79%
ROCE 11.72%
ROIC 9.26%
ROICexc 10.04%
ROICexgc 10.04%
OM 20.68%
PM (TTM) 3.2%
GM 37.6%
FCFM N/A
ROA(3y)2.9%
ROA(5y)-5.69%
ROE(3y)4.91%
ROE(5y)-7.86%
ROIC(3y)8.16%
ROIC(5y)N/A
ROICexc(3y)9.9%
ROICexc(5y)N/A
ROICexgc(3y)10.18%
ROICexgc(5y)N/A
ROCE(3y)10.33%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.15
Cap/Depr 467.81%
Cap/Sales 30.54%
Interest Coverage 250
Cash Conversion 106.7%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.35
Altman-Z 0.16
F-Score5
WACC9.34%
ROIC/WACC0.99
Cap/Depr(3y)4701.66%
Cap/Depr(5y)4096.58%
Cap/Sales(3y)58.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)29.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%22.92%
Revenue Next Year5.19%
Revenue Next 2Y26.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1622.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18.19%
OCF growth 3YN/A
OCF growth 5YN/A